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Molecular genotyping ofM.tuberculosis is an important laboratory tool in the context of
emerging drug resistant TB. The standard 24-loci MIRU-VNTR typing includes PCR amplifi-
cation followed by the detection and sizing of PCR fragments using capillary electrophoresis
on automated sequencers or using agarose gels. The QIAxcel Advanced systemmight
offer a cost-effective medium-throughput alternative.
Methods
Performance characteristics of the QIAxcel Advanced platform for the standard 24 VNTR
loci panel was evaluated at two centres on a total of 140 DNA specimens using automated
capillary electrophoresis as a reference method. Additionally 4 hypervariable MIRU-VNTR
loci were evaluated on 53 crude DNA extracts. The sizing accuracy, interlaboratory repro-
ducibility and overall instrument’s performance were assessed during the study.
Results
An overall concordance with the reference method was high reaching 98.5% and 97.6% for
diluted genomic and crude DNA extracts respectively. 91.4% of all discrepancies were
observed in fragments longer than 700bp. The concordance for hypervariable loci was
lower except for locus 4120 (96.2%). The interlaboratory reproducibility agreement rates
were 98.9% and 91.3% for standard and hypervariable loci, respectively. Overall perfor-
mance of the QIAxcel platform forM.tuberculosis genotyping using a panel of standard loci
is comparable to that of established methods for PCR fragments up to 700bp. Inaccuracies
in sizing of longer fragments could be resolved through using in-house size markers or intro-
duction of offset values. To conclude, the QiaXcel system could be considered an effective
alternative to existing methods in smaller reference and regional laboratories offering good
performance and shorter turnaround times.
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Background
The development and introduction of molecular genotyping methods forM. tuberculosis has
significantly improved our knowledge of TB transmission, bacterial phylogeny and evolution
[1]. PCR-based genotyping methods including multilocus MIRU-VNTR require small
amounts of non-purified DNA and produce results in a digital format enabling portability of
results and creation of national and international databases for routine and research purposes
[2, 3]. More recently, whole genome next generation sequencing technologies became available
providing even higher discriminatory power [4].
MIRU-VNTR typing utilizes variations in repetitive sequences which are not under selec-
tion pressure and evolve relatively rapidly making them suitable for prospective molecular epi-
demiological investigations and surveillance purposes [3, 5]. MIRU-VNTR genotyping using a
standardised set of 24 loci has become an international standard and is currently in use for rou-
tineM. tuberculosis genotyping in many European countries and globally [6]. The discrimina-
tory power of MIRU-VNTR typing generally depends on the number and set of loci used and
could be further improved by inclusion of hypervariable loci especially in settings where highly
homogenous genotypes (East Asian lineage eg Beijing) prevail [7, 8].
National or subnational TB molecular surveillance systems based on multilocus VNTR typ-
ing have been established in several EU countries and pilot international databases developed
[9]. Genotyping is currently recognized as an essential tool for tracing outbreaks, transmission
and surveillance purposes to facilitate public health interventions and studyM. tuberculosis
population structure in diagnostic and research contexts. Multicenter proficiency studies con-
ducted in 2009 and 2010 demonstrated improvements in both inter- and intralaboratory repro-
ducibility of genotyping results also highlighting specific issues including lack of
standardization and poorer performance associated with the PCR fragments separation using
manual electrophoresis [9, 10].
Both commercial and in-house methods are currently in use for VNTR typing in routine
laboratory settings; the separation and sizing of the PCR fragments could be done on auto-
mated sequencers or manually using agarose gels. The latter option, generally being the cheap-
est one, is used in many laboratories in the EU and elsewhere despite the reported
reproducibility issues [9, 10] and low throughput.
Cost and infrastructure implications may limit access of TB diagnostic laboratories to
VNTR genotyping especially in medium- and high TB and drug resistant TB burden areas
compromising their ability to perform real-time molecular epidemiology investigations. The
QiaXcel platform developed by Qiagen offers an affordable medium-throughput alternative to
the methods based on the separation of fluorescent-labelled PCR fragments using capillary
electrophoresis [11]. In a recent study performed on a convenience sample of 82M. tuberculo-
sis isolates using 15- and 24 loci standard VNTR panels, overall concordance rate with the ref-
erence method was 98.9% demonstrating potential suitability of the system for routineM.
tuberculosis genotyping [12].
In our multicentre study we aimed to assess performance the QiaXcel platform for TB geno-
typing using the most reproducible hypervariable loci [7] and establish its interlaboratory
reproducibility using a standardized well-characterized panel ofM. tuberculosis strains.
Materials and Methods
Study design and test panels
The study was conducted at two centres, Imperial College (London, UK) and the San Raffaele
Scientific Institute (Milan, Italy), where a total of 140 DNA specimens were tested using the
QIAxcel Technology inM. tuberculosisGenotyping
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QiaXcel methodology and the reference method. London and Milan centres tested 100 and 140
DNA specimens grouped into three panels as follows:
• Panel 1 comprised 60 purified genomicM. tuberculosis DNA specimens (at 1 ng/μl concen-
tration). DNA samples in this panel were identical at both sites and were used for evaluation
of interlaboratory reproducibility for standard 24 VNTR loci.
• Panels 2 (London) and 3 (Milan) each included 40 crudeM. tuberculosis DNA extracts and
were used for the assessment of the performance of QiaXcel system for genotyping using
hypervariable loci, for further adjustment of the system PCR fragments separation parame-
ters for specific loci, and for evaluation of interlaboratory reproducibility for hypervariable
loci (Panel 2 only). Panels comprised strains from various genetic lineages including Beijing
family strains (6 and 13 extracts respectively).
All panels includedM. tuberculosis strains from various lineages; panels 2 and 3 were specif-
ically enriched with Beijing family strains to test the performance of the system for highly con-
served genotyped using hypervariable loci. Research was carried out on theM. tuberculosis
DNA specimens stored in the laboratories as a part of past proficiency testing schemes (geno-
mic DNAs) and past research projects (crude DNAs) and did not involve any human subjects,
specimens or tissues. DNA specimens were fully anonymised, any information obtained could
not be traced back to the originalM. tuberculosis cultures or patients and no patient informa-
tion was collected/analysed therefore ethical approval was not sought.
VNTR loci and PCR
In the current study, we evaluated the performance of the system using a standardised set of 24
VNTR loci and four hypervariable loci (VNTR 3232, 1982, 3820, and 4120). PCR fragments
for all VNTR loci were generated individually in monoplex PCRs using sets of primers and
conditions as outlined in previous publications and manuals [6, 7, 13]. For the analysis on
QiaXcel system, unlabelled primers were used. PCR was performed in a volume of 20μl and
upon completion of the amplification the PCR plate was loaded onto the QiaXcel analyser for
the fragment separation and allele calling. Negative controls (with purified water instead of
DNA) and size marker were included into each run.
Reference methods
In London, in-house PCR with fluorescent-labelled primers followed by fragment analysis
using an automated capillary sequencer Beckman Coulter CEQ8000 was used as the reference
method. PCR, fragment separation, sizing and allele calling was done as described previously
[14]. Labelled primer sequences were identical to unlabelled ones.
In Milan, reference values were obtained by using the 24 MIRU-VNTR typing kit (Genosc-
reen, Lille, France), made up of 6 different multiplex (quadruplex) PCRs. The run was per-
formed by using an automatic sequencer, 3730 DNA analyzer (Applied Biosystems, California,
USA), and then analyzed by proprietary GeneMapper1 v3.7 software. Hypervariable loci were
characterized by a simplex PCR followed by the PCR products analysis on 3% agarose gel.
In both centers, numbers of repeats in individual loci were entered into Excel spreadsheets
and concordance with QiaXcel results was analysed.
PCR fragment separation and allele calling using QiaXcel
PCR fragment separation on QiaXcel system was performed according to the manufacturer’s
recommendations as described previously [12]. Briefly, undiluted PCR products in a 96-well
QIAxcel Technology inM. tuberculosisGenotyping
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plate were loaded onto the system, and PCR fragments separation was performed for 1,700 s at
2 kV with an alignment marker 15 to 3,000 bp and size marker 100 to 2,500 bp. Fragment siz-
ing and allele calling was performed automatically by the QiaXcel software using expected PCR
fragment sizes [7, 13]; tolerance for individual loci was calculated as described previously [12].
Test results (number of repeats in individual loci) were exported and entered into Excel spread-
sheets for further analysis. If a PCR product was missing/not detected on the QiaXcel system,
PCR and separation was repeated once and this result was considered final and entered in the
database. In case of multiple peaks on QiaXcel system, histograms were visually examined by
an operator and allele assignation was made based on recommendations [13].
Performance and interlaboratory reproducibility assessment
The performance and accuracy of the QiaXcel system was assessed through calculation of over-
all and individual 28 loci concordance rates between the reference and QiaXcel methods
results. To evaluate interlaboratory reproducibility, agreement rates between the QiaXcel
results obtained at the two laboratories for the isolates included in the Panel 1 and Panel 2 were
calculated.
Results
QiaXcel test performance characteristics
Standard loci. Performance of the assay for a standard 24 VNTR loci was assessed at both
centres using two panels ofM. tuberculosis DNA specimens (diluted genomic DNA and crude
DNA extracts). In total, 100 DNA samples were tested with a total of 2,400 assays run at each
centre. PCR fragment sizes as determined by the reference methods varied significantly
depending on the number of copies within specific VNTR loci with the shortest (136 bp) and
longest (1374 bp) fragments seen in loci 2163b and 4052, respectively (Fig 1)
Overall readability and agreement rates between QiaXcel results and reference values were
high. Readability was analysed separately for the panels comprising genomic and crude DNA;
in the latter panel the PCR failure rate was greater (4.6%, N = 44) compared to genomic DNA
Fig 1. Sizes of PCR fragments determined by the QiaXcel system. A–Standard loci. B–Hypervariable
loci.
doi:10.1371/journal.pone.0149435.g001
QIAxcel Technology inM. tuberculosisGenotyping
PLOS ONE | DOI:10.1371/journal.pone.0149435 March 3, 2016 4 / 11
(0.4%, N = 6). The greatest number of PCR failures was observed in panel 2 formed of 40 non-
preselected (routine) crude DNA extracts analysed in London; nearly all PCR failures (N = 31)
were confined to two isolates from Panel 2 in which just over half of all loci were amplified
which may indicate problems with the quality of these two particular DNA extracts. There
were no systematic differences in readability of different VNTR loci; no PCR failures were seen
in 18 and 7 loci in genomic and crude DNA extract panels, respectively.
No discrepancies between QiaXcel results and reference values were observed in 14 loci
(Table 1). For the other ten loci agreement rates varied from 59.0% (locus 4052, crude DNA
extracts) to 99.0% with disagreements seen more commonly in crude DNA extracts. In all but
one locus (VNTR4052) concordance rates were consistently over 95%. In locus 4052, poorer
agreement rates (59.0% and 80.8% for crude and genomic DNA, respectively) were associated
with the greater molecular weights of PCR fragments (Table 2).
Discrepancies between the results obtained using QiaXcel and reference methods are sum-
marised in Table 2. Discrepant results almost exclusively (74/81, 91.4%) were due to an overes-
timation of the PCR fragment sizes>700 bp and subsequent incorrect calculation of the
number of repeats within respective loci seen on the QiaXcel system. In most cases, except in
loci 3690 and 2163b, the number of copies was overestimated by one reflecting an incorrect siz-
ing of larger PCR fragments due to observed lengths exceeding tolerance values pre-set on the
system. In locus 2163b in three specimens (Panels 1 and 2 in London) multiple peaks and/or
“bell-shaped” distribution of peaks on histogram were observed which made unambiguous
Table 1. Combined agreement rates between QiaXcel and reference methods.
VNTR locus Concordance, %
Position Alias Panel 1 (diluted gDNA) Panels 2 and 3 (crude DNA)
154 MIRU2 100 100
424 100 98.8
577 ETR-C 100 100
580 MIRU4 100 98.8
802 MIRU40 100 100
960 MIRU10 100 100
1644 MIRU16 98.3 95.0
1955 95.0 100
2059 MIRU20 100 100
2163b 95.8 97.4
2165 ETR-A 96.7 100
2347 100 100
2401 100 100
2461 ETR-B 100 100
2531 MIRU23 100 100
2687 MIRU24 100 100
2996 MIRU26 100 100
3007 MIRU27 100 98.8
3171 100 98.8




4348 MIRU39 100 100
doi:10.1371/journal.pone.0149435.t001
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sizing and calculation of number of repeats challenging even using visual examination of histo-
grams. Remaining discrepant results (n = 4) were sporadic and not confined to any specific
loci.
Hypervariable loci. Performance of the QiaXcel for hypervariable VNTR loci (1982; 3232;
3820; and 4320) was tested using crude extracts included in Panel 2 (London) and Beijing iso-
lates (N = 13) from Panel 3 (Milan). PCR fragment sizes for hypervariable loci as detected by
the reference method are presented in Fig 1.
Within this group, the PCR failure rate varied between loci substantially. It was higher for
loci 1982 and 3232 (15.4% and 7.8%, respectively) while in locus 4120 all results were readable.
Agreement between QiaXcel and reference values for hypervariable loci also varied being low
for three loci (34.7%, 59.4%, and 61.5% for loci 3232, 1982, and 3820, respectively) and high for
locus 4120 (96.2%). Discrepancies between the results obtained using QiaXcel and reference
methods for hypervariable loci are summarised in Table 3.
Both PCR failures and discordant results were mainly confined to long PCR fragments
exceeding 700 bp in size. Overestimation of PCR fragment sizes by 50–100 bp seen on the
QiaXcel system led to incorrect assignation of allelic variant/number of repeats, specifically in
loci 1982 and 3232. In five specimens with a larger number of repeats in loci 1982 and 3232 (9
and 15–18, respectively), stutter peaks (1–3 copies) were miscalled instead (Fig 2), and in three
more cases no peaks were observed due to insufficient separation time. Notably, Beijing family
strains known to have larger numbers of copies in loci 3232 and 1982 were the most problem-
atic; for non-Beijing strains concordance rates for all hypervariable loci were significantly bet-
ter being as high as 100% for loci 3820 and 4120 (Table 3).
Table 2. Discrepant results for standard loci across two centres.
Loci No of discrepantresults Qiaxcel Reference
No of repeats PCR fragment size bp (range) No of repeats
424 1 7 894 6
580 1 9 868 8
1644 6 4, 7, 9 777–1042 3, 6, 8
1955 6 12 776 11
2163b 7 1, 2, 13, Multiple peaks 146–974 4, 6, 2/3, 12,1, 8,12
2165 4 10,13 945–1170 9,12
3007 1 8 922 7
3171 1 7/8 704/758 7
3690 7 9, >15, 7, 9, 3, 6, 3/5 446- >1142 8, 13, 2, 8, 8, 10, 5
4052 55 7, 8, 9, 10, 11, 12 1019–1509 6, 7, 8, 9, 10, 11
doi:10.1371/journal.pone.0149435.t002
Table 3. Discrepant results for hypervariable loci.
Loci No of
discrepantresults
Qiaxcel Reference Agreement rates
No of repeats PCR fragment size
(range)
No of repeats Beijing Non-
Beijing
1982 16 2, 10, 1/9, 9, 1, 8, 9 308–1010 10, 9, 8, 8, 9, 9, <11 59.4 71.4
3232 24 1/3, 15, 2, 6, 3, 7, 5, 1/2/3, 1/2, 13,
13, 22, 14, 14, 13
309–1037 16, 13, 10, 5, 7, 5, 3, 14, 18, 14,
16, >23, 16, 17, 15
34.7 77.4
3820 10 15, 13 1014–1128 14, 12 61.5 100.0
4120 1 16 >1188 15 96.2 100.0
doi:10.1371/journal.pone.0149435.t003
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Interlaboratory reproducibility
Interlaboratory reproducibility was assessed through comparing data generated at both labora-
tories using Panels 1 (for standard loci) and 2 (for hypervariable loci). Overall agreement rates
were good (Fig 3) with the number of discrepancies (N = 28) comprising 0.9% of the total num-
ber of PCR assays.
Results between the two laboratories were fully concordant for 19 standard VNTR loci; for
the other five standard loci and four hypervariable loci agreement rates varied from 91.7% to
98.3% and from 81.8% to 96.9%, respectively. Again, discordances were predominantly seen in
specimens with relatively large numbers of repeats in specific VNTR loci with the greatest
number of discordances seen in loci 2163b, 3232, 3820, 2165, and 4052. There were no major
differences in interlaboratory reproducibility rates between standard and hypervariable loci.
Discussion
In the current multicentre study performed at two European laboratories in Milan and Lon-
don, we aimed to assess performance characteristics and establish interlaboratory reproducibil-
ity of the innovative QiaXcel system for the multilocus VNTR genotyping ofM. tuberculosis
using panels of standard and hypervariable loci. Overall performance characteristics of the sys-
tem for standard loci were high with readability rates of 99.6% and 95.4% for the diluted geno-
mic and crude DNA extracts, respectively. Agreement rates vs reference values for the PCR
fragments sized 136–758 bp were excellent reaching 99.9% with the number of discordant
results (n = 4) accounting for 2.2% of all discrepancies. Excellent interlaboratory agreement
rates were observed in our study (99.1%) confirming reproducibility of the method and, impor-
tantly, potential portability of results between different laboratories both for standard and
hypervariable loci. These findings are in agreement with earlier reports and demonstrate a
Fig 2. Example of an incorrect Locus 3232 peak calling on the QiaXcel system.
doi:10.1371/journal.pone.0149435.g002
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potential applicability of the QiaXcel system inM. tuberculosis VNTR genotyping using both
genomic and crude DNA extracts; it also highlighted persistent problems with higher molecu-
lar weight fragments reported in earlier studies [11, 12].
Results of our study suggest that differences in quality and concentrations of DNA speci-
mens have only a minor impact on the performance of the system (Table 1). Accuracy
depended primarily on the PCR fragment length regardless of the locus analysed being subopti-
mal for sizes>750 bp which translated into the poor performance of the system for a small
number of both standard (4052) and hypervariable (1982, 3232, and 3820) loci where variants
with a greater number of copies occur frequently. Problems with sizing of longer PCR frag-
ments on capillary electrophoresis systems have been reported previously [15, 16]. Reasons for
inaccurate sizing and subsequent incorrect assignation of allelic variants on capillary systems
include anomalous migration of the DNA due to secondary structures, variations in migration
rates under normal and denaturing conditions [13, 17] as well as suboptimal fragment separa-
tion parameters and hardware limitations. These problems could be both loci-specific and PCR
fragment size-dependant and require optimization of both separation procedures and peak
calling algorithms. Previously loci 4052, 1982, and 3232 have been found to be particularly
problematic [15] which is in agreement with our study results.
Experimental determination of offset values for specific loci using reference strains with
known numbers of VNTR copies in each locus and introduction of appropriate changes into
Fig 3. Interlaboratory agreement rates. Hypervariable loci shown in red colour. In cases where results from both laboratories were incorrect, these values
were not included in discrepancies.
doi:10.1371/journal.pone.0149435.g003
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the calling algorithms and reference tables may help to improve accuracy of PCR fragment siz-
ing and eliminate errors in assignation of allelic variants [13, 15]. Modified calling tables with
offset values for locus 4052 were tested in one of the study laboratories with excellent results
(data not shown) significantly improving performance of the system. This approach has
proven effective in earlier studies for other loci [15, 18, 19] and could be recommended for
locus 4052 and other “difficult to type” loci. An alternative approach utilising allele-specific
size markers for individual or groups of loci [11, 15] is currently used in commercial VNTR
genotyping kits for capillary sequencers (eg Genoscreen, Lille, France) and proved effective for
VNTR genotyping both on cultures and clinical specimens [7, 20]. Both approaches require a
careful calibration of the system using reference M. tuberculosis and/orM. bovis BCG strains to
ensure accuracy and reproducibility of results.
Other issues, including missing higher molecular weight peaks, could be resolved through
adjustment of the separation parameters, including longer separation time and lower voltage.
This would increase the resolution of the system and ensure effective separation of PCR frag-
ments>1000 bp potentially eliminating problems with loci 4052, 1982, 3232, and 3820 provid-
ing the system has been calibrated to take offset values into account.
To conclude, the QiaXcel system could be considered an effective alternative to existing
automated capillary electrophoresis sequences in smaller reference and regional laboratories
with intermediate workload offering a performance superior to manual gel electrophoresis
PCR fragment separation, shorter turnaround times and relative technical simplicity. Cost
effectiveness of the system is yet to be evaluated in line with national and international policies
onM. tuberculosis genotyping in given settings. Importantly, the system could be potentially
used for automated PCR fragment separation and sizing in other typing technologies, including
indel mapping and multilocus SNP-based typing [21, 22] which makes it a versatile tool for
both routine epidemiological investigations and phylogenetic/evolutionary research. Existing
problems with inaccurate sizing of larger DNA fragments in loci 4052, 3232, and 1982 could be
addressed through adjustment of calling algorithms using either offset values or allelic size
markers with prior calibration of the system.
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